ODP644 Oral Dosing of Progestogenic Androgens for Male Contraception Show Low Serum Testosterone and High Acceptability in Placebo-Controlled Trials

A promising development in hormonal male contraception (HMC) is a class of bifunctional prodrugs that combine both androgenic and progestogenic activities into a single molecule. Examples of these prodrugs currently being studied are dimethandrolone undecanoate (DMAU) and 11β-methyl-19-nortestostero...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsohn, Tamar, Nguyen, Brian, Fernando, Frances, Brown, Jill, Blithe, Diana, Lee, Min, Yuen, Fiona, Swerdloff, Ronald, Liu, Peter, Wang, Christina, Farrant, Maritza, Anawalt, Bradley, Thirumalai, Arthi, Bremner, William, Page, Stephanie, Amory, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625429/
http://dx.doi.org/10.1210/jendso/bvac150.1398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625429/
http://dx.doi.org/10.1210/jendso/bvac150.1398

Ejemplares similares